Clinical Trial: PRISM Neurofeedback Training for MDD Anhedonic Patients
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Depression
Study Type: INTERVENTIONAL
Official Title: Personalizing Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia Using Clinical Biomarkers for MDD Subtypes
Brief Summary:
The goal of this interventional double-blind study is to demonstrate the safety and efficacy of PRISM neurofeedback training within an MDD Anhedonia sample.The goals of this study include:Demonstrating the safety and efficacy of Prism Neurofeedback training within an MDD Anhedonia sample;Identifying clinical profile/symptoms-based biomarkers (e.g., Hamilton Depression Rating Scale - HDRS-21, Dimensional Anhedonia Rating Scale - DARS, Snaith-Hamilton Pleasure Scale for Clinicians SHAPS) scores that can be used…
Read more